CPT Code 91320: COVID-19 Vaccine, Tris-Sucrose Formulation, for Intramuscular Use

The administration of the COVID-19 vaccine, represented by CPT code 91320, should be billed using administration code 90480. As of late 2023, CPT 90480 is the designated code for administering any COVID-19 vaccine, including those identified by 91320, and replaces all previous, vaccine-specific administration codes.

CPT code 91320 is not used for pediatric doses. It specifically describes the Pfizer-BioNTech COVID-19 vaccine in a 30 mcg/0.3 mL tris-sucrose formulation for intramuscular use in patients 12 years and older.

No, CPT code 91320 does not include administration. It is a product code that only describes the vaccine itself. The administration of the vaccine must be reported separately using code 90480, which covers the work of giving the vaccine, counseling, and related services.